Mastenbroek, M H3; Pedersen, Susanne S.5; Versteeg, H4; Doevendans, P A4; Meine, M4
1 Department of Psychology, Det Sundhedsvidenskabelige Fakultet, SDU2 INSIDE, Department of Psychology, Det Sundhedsvidenskabelige Fakultet, SDU3 Cardiology, Department of Heart and Lung, University Medical Center, Heidelberglaan 100, PO Box 85500, 3584 CX, Utrecht, the Netherlands, firstname.lastname@example.org unknown5 Department of Psychology, Det Sundhedsvidenskabelige Fakultet, SDU
Lessons learned and future directions
The lifesaving benefits of implantable cardioverter defibrillator (ICD) therapy are more and more weighted against possible harm (e.g. unnecessary device therapy, procedural complications, device malfunction etc.) which might have adverse effects on patients' perceived health status and quality of life. Hence, there has been an increasing interest in the optimisation of ICD programming to prevent inappropriate and appropriate but unnecessary device therapy. The purpose of the current report is to give an overview of research into the optimisation of ICD programming and present the design of the on-going ENHANCED-ICD study. The ENHANCED-ICD study is a prospective, safety monitoring study enrolling 60 primary and secondary prophylactic ICD patients at the University Medical Center Utrecht. Patients implanted with any type of ICD with SmartShock technology(TM), and between 18-80 years of age, were eligible to participate. In all patients a prolonged detection of 60/80 intervals was programmed. The primary objective of the study is to investigate whether enhanced programming to further reduce ICD therapies is safe. The secondary objective is to examine the impact of enhanced programming on (i) antitachycardia pacing and shocks (both appropriate and inappropriate) and (ii) quality of life and distress. The first results of the ENHANCED-ICD study are expected in 2015.
Netherlands Heart Journal, 2014, Vol 22, Issue 10, p. 415-20